Jim Simons's position in Sarepta Therapeutics is currently worth $72.2 Million. That's 0.11% of their equity portfolio (224th largest holding). The first Sarepta Therapeutics trade was made in Q4 2014. Since then Jim Simons bought shares sixteen more times and sold shares on fourteen occasions. The stake costed the investor $52 Million, netting the investor a gain of 39% so far.